Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Jakob Appel Østergaard, Mark E. Cooper, Karin Jandeleit‐Dahm
Journal of Nephrology (2020) Vol. 33, Iss. 5, pp. 917-929
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections
Patricia González, Pedro Lozano, Gaspar Ros, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9352-9352
Open Access | Times Cited: 202
Mitochondrial dysfunction in diabetic tubulopathy
Lan Yao, Xianhui Liang, Yingjin Qiao, et al.
Metabolism (2022) Vol. 131, pp. 155195-155195
Open Access | Times Cited: 95
Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction
Emelie Lassén, Ilse S. Daehn
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9456-9456
Open Access | Times Cited: 96
NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy
Duojun Qiu, Shan Song, Yuhan Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway
Chenlei Lv, Tianyang Cheng, Bingbing Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 29
Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
Yaoxia Zhang, Yuanyuan Qu, Ruiping Cai, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176699-176699
Closed Access | Times Cited: 9
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease
Jakob Appel Østergaard, Jay C. Jha, Arpeeta Sharma, et al.
Clinical Science (2022) Vol. 136, Iss. 2, pp. 167-180
Open Access | Times Cited: 35
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
Thomas Bais, Ron T. Gansevoort, Esther Meijer
Drugs (2022) Vol. 82, Iss. 10, pp. 1095-1115
Open Access | Times Cited: 24
Iron Metabolism and Ferroptosis in Diabetic Kidney Disease
Fangxin Mu, Ping Luo, Yuexin Zhu, et al.
Cell Biochemistry and Function (2025) Vol. 43, Iss. 4
Closed Access
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease
Sih Min Tan, Matthew Snelson, Jakob Appel Østergaard, et al.
Antioxidants and Redox Signaling (2021) Vol. 37, Iss. 10-12, pp. 781-801
Open Access | Times Cited: 31
Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review
Lingli Xie, Wenfang Xia
Life Sciences (2022) Vol. 300, pp. 120543-120543
Closed Access | Times Cited: 21
Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells
Theodoros Eleftheriadis, Georgios Pissas, Georgios Filippidis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16107-16107
Open Access | Times Cited: 19
Effects of antioxidants on diabetic kidney diseases: mechanistic interpretations and clinical assessment
Yuting Sun, De Jin, Ziwei Zhang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathway
Xiaochun Zeng, Yuan Tian, Xianming Liang, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
A kidney-targeted chitosan-melanin nanoplatform for alleviating diabetic nephropathy through modulation of blood glucose and oxidative stress
Jinghua Sun, Juanjuan Han, Jie Dong, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130663-130663
Closed Access | Times Cited: 4
Advances of Iron and Ferroptosis in Diabetic Kidney Disease
Jiayi Chu, Kewu Wang, Lulu Lu, et al.
Kidney International Reports (2024) Vol. 9, Iss. 7, pp. 1972-1985
Open Access | Times Cited: 4
SGLT2 inhibition to target kidney aging
Elisa Russo, Valentina Zanetti, Lucia Macciò, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 4
Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway
Yanhong Wang, Jia Yang, Xinyue Chang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 16
Closed Access | Times Cited: 4
SGLT2 inhibitors, sodium and off-target effects: an overview
Antonio De Pascalis, Giuseppe Cianciolo, Irene Capelli, et al.
Journal of Nephrology (2020) Vol. 34, Iss. 3, pp. 673-680
Closed Access | Times Cited: 29
Diosgenin Inhibits ROS Generation by Modulating NOX4 and Mitochondrial Respiratory Chain and Suppresses Apoptosis in Diabetic Nephropathy
Yujie Zhong, Lei Wang, Ruyi Jin, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2164-2164
Open Access | Times Cited: 10
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
Maoying Wei, Xingxing Liu, Zhijuan Tan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Role of bile acid receptors in the development and function of diabetic nephropathy
Yuanyuan Fang, Minjing Qin, Qitong Zheng, et al.
Kidney International Reports (2024) Vol. 9, Iss. 11, pp. 3116-3133
Open Access | Times Cited: 3
Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline
Vasile Valeriu Lupu, Ingrith Miron, Laura Mihaela Trandafir, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation
Xing Wang, Caina Li, Yi Huan, et al.
Chemico-Biological Interactions (2021) Vol. 338, pp. 109427-109427
Closed Access | Times Cited: 23
Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities
Ara Aboolian, Sofia Urner, Michael Roden, et al.
Handbook of experimental pharmacology (2022), pp. 269-307
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top